Coherus BioSciences, Inc. 4
4 · Coherus BioSciences, Inc. · Filed Jan 5, 2017
Insider Transaction Report
Form 4
Herman Alan C.
Chief Scientific Officer
Transactions
- Sale
Common Stock, $0.0001 par value
2017-01-03$28.60/sh−683$19,536→ 124,451 total - Sale
Common Stock, $0.0001 par value
2017-01-03$27.90/sh−10,650$297,186→ 125,134 total
Holdings
- 300,164(indirect: By Trust)
Common Stock, $0.0001 par value
Footnotes (4)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $27.50 to $28.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The transaction was executed in multiple trades in prices ranging from $28.525 to $28.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F4]These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.